Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 8961-8970 Newer>

Pharmaceutical Executive October 1, 2014 Ogden & Holtman	Open-Source Option Against Capital Crunch Is crowdfunding an attractive alternative to finance pharma and biotech start-ups?
Pharmaceutical Executive October 1, 2014 Lee Jones	Our Body's Secret Weapon -- The Human Microbiome New research on the role of microbes in fighting disease is transforming the way medicine views bacteria.
Pharmaceutical Executive October 1, 2014 Stan Bernard	Gain a Competitive Edge: Think Like a Navy SEAL Pharmaceutical professionals, teams, and organizations can succeed at an elite level by tackling the tough mental challenges of Navy SEAL training.
Pharmaceutical Executive October 1, 2014 Jill Wechsler	Ebola Crisis Challenges Pharma R&D Companies gain support and pressure to deliver new treatments for spreading outbreak.
Pharmaceutical Executive October 1, 2014 David Dalke	New Patent-Defense Path for Pharma Inter Partes Review can potentially offer a more economical and streamlined litigation strategy for pharma and biotech players.
Pharmaceutical Executive October 1, 2014	Eruptions on the Drug-Pricing Horizon in Europe An escalating political debate over pharma pricing and reimbursement nears the boiling point.
Pharmaceutical Executive October 1, 2014 William Looney	Youthquake You may not realize it, but the demographic "youth skew" in America is shaping healthcare and that's a good thing.
Chemistry World October 10, 2014 Phillip Broadwith	Endo outbids QLT for Auxilium merger US biotech Auxilium has backed out of a merger with Canadian firm QLT, in favor of a deal with US-based Endo.
Information Today October 9, 2014	Annual Review of Virology Debuts The Annual Review of Virology captures and describes advances in the medical community's understanding of viruses in animals, plants, bacteria, archaea, fungi, and protozoa.
Chemistry World October 8, 2014 Phillip Broadwith	EMA finalizes trial transparency rules The European Medicines Agency has finalized its policy for sharing data from clinical trials.
<Older 8961-8970 Newer> Return to current articles.